PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.
Cancers
Pignochino, Ymera Y; Crisafulli, Giovanni G; Giordano, Giorgia G; Merlini, Alessandra A; Berrino, Enrico E; Centomo, Maria Laura ML; Chiabotto, Giulia G; Brusco, Silvia S; Basiricò, Marco M; Maldi, Elena E; Pisacane, Alberto A; Leuci, Valeria V; Sangiolo, Dario D; D'Ambrosio, Lorenzo L; Aglietta, Massimo M; Kasper, Bernd B; Bardelli, Alberto A; Grignani, Giovanni G
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational Study.
Cancers
Pignochino, Ymera Y; Crisafulli, Giovanni G; Giordano, Giorgia G; Merlini, Alessandra A; Berrino, Enrico E; Centomo, Maria Laura ML; Chiabotto, Giulia G; Brusco, Silvia S; Basiricò, Marco M; Maldi, Elena E; Pisacane, Alberto A; Leuci, Valeria V; Sangiolo, Dario D; D'Ambrosio, Lorenzo L; Aglietta, Massimo M; Kasper, Bernd B; Bardelli, Alberto A; Grignani, Giovanni G
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS